Vancouver, Canada

Troy Harasym

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 564(Granted Patents)


Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Troy Harasym

Introduction

Troy Harasym is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of lipid-encapsulated nucleic acid compositions. With a total of five patents to his name, Harasym's work has the potential to impact therapeutic delivery systems.

Latest Patents

One of Harasym's latest patents focuses on lipid-encapsulated polyanionic nucleic acid. The methods described in this patent provide a way to prepare a lipid-nucleic acid composition. The process involves combining a mixture of lipids, including a protonatable or deprotonatable lipid, with a buffered aqueous solution of charged therapeutic agents, such as polyanionic nucleic acids. This results in particles where the therapeutic agent is encapsulated within a lipid vesicle. The method allows for the production of compositions with high ratios of therapeutic agent to lipid and encapsulation efficiencies exceeding 50%.

Career Highlights

Throughout his career, Troy Harasym has worked with esteemed organizations, including the University of British Columbia and Inex Pharmaceuticals Corporation. His experience in these institutions has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Harasym has collaborated with notable colleagues, including Sean C Semple and Sandra K Klimuk. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Troy Harasym's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in lipid-encapsulated nucleic acid compositions showcases the potential for advancements in therapeutic delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…